Business

Find More: Advertising Aerospace & Defense Energy Entertainment Food & Drink Healthcare Manufacturing Retail

Latest Business

Aerospace & Defense

An Israeli Strike On Iran Wouldn’t Be First Time Israel Attacked Iranian Soil

28 Scrumptious Photos, Served By Food Photographer Of The Year Awards

SNL Cast Completely Loses It During Ryan Gosling ‘Beavis And Butt-Head’ Sketch

Denver Tops Poll As Country’s Best Weed City

Alarming Measles Outbreaks Surge Across Europe And Central Asia

Dollar General is taking a key strategy from Costco as it aims to lower costs

Adtech’s $40 billion juggernaut The Trade Desk is about to face its biggest test yet

Emergency medical bills worry Americans — and it could affect the presidential election

Aerospace & Defense

Israel’s Air Defenses Have Hugely Improved Since It Last Came Under Attack By Ballistic Missiles

Inside The Rise Of Our Place And The Always Pan

The Disney-Owned Theme Park That Pays $170 Million To Use Its Characters

Why Lovesac Continues To Grow While Other Furniture Brands Falter

Intense Exercise Is Not Harmful For People With Long Covid, Study Finds

A California McDonald’s franchisee says fast food would be ‘unaffordable’ if she raised prices enough to cover the new $20 minimum wage

Why some adtech companies are soaring even as the end of cookies threatens to crush the industry

This biotech startup wants to prevent unhappiness. Here’s the pitch deck Matter Neuroscience used to raise $26 million.

Aerospace & Defense

Delta And United Contracts Prohibit Single Pilot Cockpits. American’s Doesn’t.

As Spring Arrives, Here’s Some Inspiration For Your Garden

Actor Oliver Stark Opens Up About His ‘9-1-1’ Character’s Journey

The Price Of Aldi’s Expansion? It Could Be Cheaper Groceries

CMS Is Not Solomon When It Comes To Healthcare

Costco really wants nonmembers to stop eating at its food court

Inside Gen-Z sports brand Overtime’s road to $100 million in revenue and how it plans to build on the momentum

Expect AI-made prescription drugs to be ready for clinical trials in a couple of years, predicts Google DeepMind CEO